mRNA levels of CD31, CD144, CD146 and von Willebrand factor do not serve as surrogate markers for circulating endothelial cells
Circulating endothelial cells (CEC) are considered a promising marker to determine the extent of vascular damage. However, currently available and validated CEC enumeration assays are laborious, time consuming and costly, which limits their clinical utility. Here, we evaluated the feasibility of qua...
Saved in:
Published in | Thrombosis and haemostasis Vol. 104; no. 2; p. 318 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Germany
01.08.2010
|
Subjects | |
Online Access | Get more information |
Cover
Loading…
Abstract | Circulating endothelial cells (CEC) are considered a promising marker to determine the extent of vascular damage. However, currently available and validated CEC enumeration assays are laborious, time consuming and costly, which limits their clinical utility. Here, we evaluated the feasibility of quantifying mRNA levels of the endothelium-associated markers CD31, CD144, CD146 and von Willebrand factor (vWf) in peripheral blood (PB) of healthy donors, patients, and human umbilical veins by real-time reverse transcriptase polymerase chain reaction (RT-PCR) and their use as surrogate markers for CEC. Whole blood samples and CD146+ cell-enriched fractions were assessed for mRNA and protein expression of CD31, CD144, CD146 and vWf by RT-PCR and flow cytometry, respectively. We showed the feasibility to detect endothelial mRNA isolated from HUVEC numbers as low as 10. However, no endothelial mRNA could be measure in whole blood samples, and only low levels of CD31 and CD146 mRNA were detected in suspensions of isolated CEC with numbers up to 4,450 CEC per sample. We conclude that mRNA levels of CD31, CD144, CD146 and vWf in whole blood as detected by real time RT-PCR cannot be used as biomarkers for end-stage endothelial cells such as CEC. |
---|---|
AbstractList | Circulating endothelial cells (CEC) are considered a promising marker to determine the extent of vascular damage. However, currently available and validated CEC enumeration assays are laborious, time consuming and costly, which limits their clinical utility. Here, we evaluated the feasibility of quantifying mRNA levels of the endothelium-associated markers CD31, CD144, CD146 and von Willebrand factor (vWf) in peripheral blood (PB) of healthy donors, patients, and human umbilical veins by real-time reverse transcriptase polymerase chain reaction (RT-PCR) and their use as surrogate markers for CEC. Whole blood samples and CD146+ cell-enriched fractions were assessed for mRNA and protein expression of CD31, CD144, CD146 and vWf by RT-PCR and flow cytometry, respectively. We showed the feasibility to detect endothelial mRNA isolated from HUVEC numbers as low as 10. However, no endothelial mRNA could be measure in whole blood samples, and only low levels of CD31 and CD146 mRNA were detected in suspensions of isolated CEC with numbers up to 4,450 CEC per sample. We conclude that mRNA levels of CD31, CD144, CD146 and vWf in whole blood as detected by real time RT-PCR cannot be used as biomarkers for end-stage endothelial cells such as CEC. |
Author | Debets, Reno Kraan, Jaco Sleijfer, Stefan Strijbos, Michiel H Lamers, Cor H J van Krimpen, Brigitte A Gratama, Jan Willem |
Author_xml | – sequence: 1 givenname: Michiel H surname: Strijbos fullname: Strijbos, Michiel H organization: Laboratory of Translational Tumorimmunolgy, Department of Medical Oncology, Erasmus University Medical Center, Daniel den Hoed Cancer Center, Rotterdam, The Netherlands – sequence: 2 givenname: Brigitte A surname: van Krimpen fullname: van Krimpen, Brigitte A – sequence: 3 givenname: Reno surname: Debets fullname: Debets, Reno – sequence: 4 givenname: Jaco surname: Kraan fullname: Kraan, Jaco – sequence: 5 givenname: Stefan surname: Sleijfer fullname: Sleijfer, Stefan – sequence: 6 givenname: Jan Willem surname: Gratama fullname: Gratama, Jan Willem – sequence: 7 givenname: Cor H J surname: Lamers fullname: Lamers, Cor H J |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/20589320$$D View this record in MEDLINE/PubMed |
BookMark | eNo1kE1LAzEYhHOo2Fq9eZb3B7j6Zjf7kWOpHxWKghQ8lmzypq6mSUm2BU_-dVeql3kYGIZhztjIB0-MXXK84bzC29UCZYZNhqUUIzbBQmBW5aIcs7OUPhB5JWR5ysY5lo0scpyw7-3r8wwcHcglCBbmdwW_HpQLcUQFyhs4BA9vnXPUxl9rle5DBBPAhx4SxQOBSpD2MYaN6gm2Kn5STGCHlO6i3jvVd34D5E3o38l1yoEm59I5O7HKJbr445StHu5X80W2fHl8ms-WmS6F7DOFWuS6aA3JpiDBORqtOKe2bmqhlVBS2QJbaZFkTdrKqjaGhkt0xblq8ym7Otbu9u2WzHoXu2Hi1_r_iPwHb6Ze7w |
CitedBy_id | crossref_primary_10_1007_s10439_011_0354_x crossref_primary_10_1016_j_thromres_2010_11_019 |
ContentType | Journal Article |
DBID | CGR CUY CVF ECM EIF NPM |
DOI | 10.1160/TH09-08-0594 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | no_fulltext_linktorsrc |
Discipline | Medicine |
ExternalDocumentID | 20589320 |
Genre | Evaluation Studies Journal Article |
GroupedDBID | --- .55 .GJ 0R~ 0VX 123 1KJ 4.4 53G 5RE AAQQT ABJNI ABOCM ACGFO ACGFS AENEX AFFNX AHRSK ALMA_UNASSIGNED_HOLDINGS BR6 C45 CGR CS3 CUY CVF DU5 EBS ECM EIF EJD F5P H13 J5H NPM OVD P2P RTC RTE SJN TEORI X7M ZGI ZXP |
ID | FETCH-LOGICAL-c549t-a0c42c3bde983e4110dca11eb7874ca4a9af30b9f0e97ecf967dde160c611ab2 |
ISSN | 0340-6245 |
IngestDate | Thu Jan 02 22:21:07 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c549t-a0c42c3bde983e4110dca11eb7874ca4a9af30b9f0e97ecf967dde160c611ab2 |
PMID | 20589320 |
ParticipantIDs | pubmed_primary_20589320 |
PublicationCentury | 2000 |
PublicationDate | 2010-08-01 |
PublicationDateYYYYMMDD | 2010-08-01 |
PublicationDate_xml | – month: 08 year: 2010 text: 2010-08-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Germany |
PublicationPlace_xml | – name: Germany |
PublicationTitle | Thrombosis and haemostasis |
PublicationTitleAlternate | Thromb Haemost |
PublicationYear | 2010 |
SSID | ssj0016495 |
Score | 1.9822447 |
Snippet | Circulating endothelial cells (CEC) are considered a promising marker to determine the extent of vascular damage. However, currently available and validated... |
SourceID | pubmed |
SourceType | Index Database |
StartPage | 318 |
SubjectTerms | Adult Antigens, CD - genetics Apoptosis Biomarkers - blood Cadherins - genetics CD146 Antigen - genetics Cells, Cultured Endothelial Cells - metabolism Endothelial Cells - pathology Feasibility Studies Female Flow Cytometry Humans Immunomagnetic Separation Male Middle Aged Platelet Endothelial Cell Adhesion Molecule-1 - genetics Reproducibility of Results Reverse Transcriptase Polymerase Chain Reaction RNA, Messenger - blood T-Lymphocytes - metabolism von Willebrand Factor - genetics |
Title | mRNA levels of CD31, CD144, CD146 and von Willebrand factor do not serve as surrogate markers for circulating endothelial cells |
URI | https://www.ncbi.nlm.nih.gov/pubmed/20589320 |
Volume | 104 |
hasFullText | |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELa2ICEuiDeUh-bALQTycNzNsWpBq0r0AEHqrbIdm261iatsyqEXfhJ_kRk7m40KiMclm421SdbzaTwznpmPsVeIA3Qq0iIus7mmaJWN5zVPYlVIi-ZRVnPru30ei8VnfnRSnMxm3ydZS5e9eqOvfllX8j9SxWsoV6qS_QfJjjfFC3iO8sUjShiPfyXj5uPxfrSitB-fkHFwmKc-8HmI_svmRPjtga_O58esaJsYvwaWnah2Uev6iAKzhghn1pdd5yiuFjWUtdP5Xg2RXnbak3y1XyLT1lSytaI4O8X811PjtjrrXKMctTihh5xJ0zg0PtfL0W7_1HfLcxUy-ygJdWlW2-oIqqRCnYN2fKCQJ8quHt9lxBjqRtOHyJBp3bhUdDIEcY9QuU-DGJMUurF4i6oQstBZclTMgZh4QGA2UbN50Nk_q39B-ZLVgjZ88AFF4E-eIOGi8VDIiEwx91V4fxi91ox7M7TDdtAtIZ5VCg4Nm1aCe5Kf8b9s6ixE8nb6StR_erjNNV_G2zTVXXZncEZgPyDrHpuZ9j679WFIt3jAvhHAIAAMnAUC2Gvw8AofAlDQgOCCLbgggAtqBwgu8OACuYYRXDCACxBcMAEXTMAFHlwPWfX-XXWwiAfGjlgXvOxjmWie6VzVppznhqNpWWuZpkbhssC15LKUNk9UaRNT7hltS7GHyytOkBZpKlX2iN1oXWueMBASPV3NZUIWfYI_tKVB51orbk02N_Ypexxm7vQidGU53czp7m9HnrHbW-w9ZzctqgHzAm3KXr30kvwB-L1y5A |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=mRNA+levels+of+CD31%2C+CD144%2C+CD146+and+von+Willebrand+factor+do+not+serve+as+surrogate+markers+for+circulating+endothelial+cells&rft.jtitle=Thrombosis+and+haemostasis&rft.au=Strijbos%2C+Michiel+H&rft.au=van+Krimpen%2C+Brigitte+A&rft.au=Debets%2C+Reno&rft.au=Kraan%2C+Jaco&rft.date=2010-08-01&rft.issn=0340-6245&rft.volume=104&rft.issue=2&rft.spage=318&rft_id=info:doi/10.1160%2FTH09-08-0594&rft_id=info%3Apmid%2F20589320&rft_id=info%3Apmid%2F20589320&rft.externalDocID=20589320 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0340-6245&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0340-6245&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0340-6245&client=summon |